FOOD ALLERGY Clinical Value of Component-Resolved Diagnostics in Peanut-Allergic Patients

METHODS. The Auvi-Q and EpiPen were evaluated by each participant in a randomly assigned order. Participantswere given a scenario that involved anaphylaxis and were instructed to simulate the use of each device using trainers that did not have a needle or contain epinephrine. Subjects were expected to perform the device test by relying on the labeling and/or voice instruction or intuition to perform the simulated injection correctly. They could not communicate with proctors before or during the test and were not given patient information leaflets. After testing both devices, participants completed a survey to indicate their preference for Auvi-Q versus EpiPen.